zidovudine has been researched along with Benign Neoplasms, Brain in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christiansen, LS; Kurkipuro, J; Määttä, AM; Piškur, J; Samaranayake, H; Stedt, H; Vuorio, T; Wirth, G; Ylä-Herttuala, S | 1 |
An, TL; Chen, XJ; Liu, J; Ren, XL; Sun, CY; Wang, LL; Wang, Q; Yu, SZ; Zhao, WJ | 1 |
Baiocchi, RA; Barth, RF; Bhatt, D; Caligiuri, MA; Eisenbeis, CF; Ferketich, A; Grecula, J; Gupta, N; Moeschberger, M; Nuovo, GJ; Peng, R; Porcu, P; Roychowdhury, S; Schmalbrock, P; Vourganti, S; Yang, W | 1 |
Pardridge, WM | 1 |
Navia, BA | 1 |
Byrne, GE; Cabral, L; Cai, JP; Harrington, WJ; Hurley, J; Jayaweera, D; Landy, H; Raez, L; Scerpella, E; Sfakianakis, G | 1 |
Balzarini, J; De Clercq, E; Naesens, L; Sobis, H; Vandeputte, M | 1 |
2 review(s) available for zidovudine and Benign Neoplasms, Brain
Article | Year |
---|---|
Blood-brain barrier drug targeting: the future of brain drug development.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Carrier Proteins; Drug Administration Routes; Drug Delivery Systems; Drug Design; Drug Industry; Genetic Therapy; Humans; Lipid Metabolism; Molecular Weight; Parkinson Disease; Primates; Recombinant Proteins; Zidovudine | 2003 |
Clinical and biologic features of the AIDS dementia complex.
Topics: AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Behavior; Biology; Brain Neoplasms; Cognition; HIV-1; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma, AIDS-Related; Psychomotor Performance; Toxoplasmosis, Cerebral; Zidovudine | 1997 |
7 other study(ies) available for zidovudine and Benign Neoplasms, Brain
Article | Year |
---|---|
Tomato thymidine kinase-based suicide gene therapy for malignant glioma--an alternative for Herpes Simplex virus-1 thymidine kinase.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Genes, Transgenic, Suicide; Genetic Therapy; Glioma; Herpesvirus 1, Human; Humans; Male; Mice, Nude; Plant Proteins; Rats; Solanum lycopersicum; Thymidine Kinase; Tumor Burden; Xenograft Model Antitumor Assays; Zidovudine | 2015 |
[Effects of azidothymidine on p33ING1b expression, apoptosis and senescence of TJ905 human glioblastoma cell line].
Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cellular Senescence; Dose-Response Relationship, Drug; Glioblastoma; Humans; Inhibitor of Growth Protein 1; Intracellular Signaling Peptides and Proteins; Nuclear Proteins; Reverse Transcriptase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Suppressor Proteins; Zidovudine | 2010 |
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
Topics: Animals; Antiviral Agents; Brain Neoplasms; Combined Modality Therapy; Epstein-Barr Virus Infections; Ganciclovir; Herpesvirus 4, Human; Humans; Kidney Transplantation; Lymphoma, B-Cell; Male; Middle Aged; Rats; RNA, Messenger; Thymidine Kinase; Up-Regulation; Xenograft Model Antitumor Assays; Zidovudine | 2003 |
Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2.
Topics: Adolescent; Adult; Anti-HIV Agents; Apoptosis; Brain Neoplasms; Drug Therapy, Combination; Female; Ganciclovir; Humans; Interleukin-2; Lymphoma, AIDS-Related; Male; Treatment Outcome; Tumor Cells, Cultured; Zidovudine | 1999 |
Drug combination treats brain cancer.
Topics: Anti-HIV Agents; Brain Neoplasms; CD4 Lymphocyte Count; Drug Therapy, Combination; Epstein-Barr Virus Infections; Ganciclovir; HIV Infections; Humans; Interleukin-2; Lymphoma, AIDS-Related; Radiotherapy, Adjuvant; Treatment Outcome; Zidovudine | 1999 |
New combination for brain cancer.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Clinical Trials as Topic; Ganciclovir; Humans; Interleukin-2; Lymphoma; Treatment Outcome; Zidovudine | 1999 |
Inhibitory effects of 9-(2-phosphonylmethoxyethyl)adenine and 3'-azido-2',3'-dideoxythymidine on tumor development in mice inoculated intracerebrally with Moloney murine sarcoma virus.
Topics: Adenine; Animals; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Mice; Moloney murine sarcoma virus; Organophosphonates; Sarcoma, Experimental; Skull Neoplasms; Zidovudine | 1990 |